Facts

Otometrics develops, manufactures and markets computer-based audiological, otoneurologic, vestibular instrumentation and sound rooms in more than 80 countries under the Madsen, Aurical, Hortmann and ICS brand names.

Otometrics is part of Natus Medical, Incorporated.

Headquarters

Otometrics | Natus Medical Denmark ApS, Hoerskaetten 9, 2630 Taastrup, Denmark (approximately 13 miles west of Copenhagen)

Tel: +45 45 75 55 55 
Fax: +45 45 75 55 59 
E-mail:otoinfo@natus.com


Company locations
Australia, Austria, Brazil, China, Denmark, France, Germany, The Netherlands, Italy, New Zealand, Norway, Spain, Sweden, United Kingdom and the United States

Family of Companies

 Company

 Founded      

 Otometrics

2001

 ICS Medical

1981

 DANPLEX

1972

 HORTMANN

1971

 MADSEN

1960

 

Certifications

  • Otometrics complies with the requirements of ISO 9001 and ISO 13485, FDA, Canadian Medical Device Regulation (CMDR) and Medical Device Directive (MDD).

  • Medical CE-mark
    The CE-mark indicates that Otometrics A/S meets the requirements of Annex II of the Medical Device Directive 93/42/EEC.

Approval is made by LNE/G-MED no. 0459.

 

Payment information

 Comment

 Company

 Currency

Account no.

 IBAN

 Swift

 Bank

Remit to email address

 Address

Customers invoiced in GBP must pay to this account

Natus Nicolet UK, Ltd.

GBP

17669682 GB46CITI18500817669682

CITIGB2L

Citibank Sort Code: 18-50-08

uk.oto.remit@natus.com

Citibank
33 Canada Square,
Canary Warf,
London E14 5LB, U.K.

Customers invoiced in USD
must pay to this account

Natus Nicolet UK, Ltd.

USD

18338515

GB46CITI18500818338515

CITIGB2L Citibank Sort Code: 18-50-08

uk.oto.remit@natus.com

Citibank
33 Canada Square,
Canary Warf,
London E14 5LB, U.K.


 

NB! All our old Nordea accounts will be closed on March 15, 2018 

 

Terms and Conditions
Natus Terms and Conditions of Sale of Goods and Services

 

Investor information

Otometrics is part of Natus Medical, Incorporated, listed on the NASDAQ Stock Exchange (NASDAQ: BABY). For more investor information please go to Natus investor information